Polymorphic CYP genes and disease predisposition--what have the studies shown so far?

Area of Science:

• Genetics and Epidemiology
• Cancer Research
• Environmental Health

Background:

• Genetic predisposition plays a role in cancer development.
• Specific gene variants in cytochrome P450 (CYP) and glutathione S-transferase (GST) enzymes are implicated in cancer risk.
• Gene-environment interactions, particularly with smoking, are critical factors in cancer etiology.

Purpose of the Study:

• To investigate the association between high-risk genotypes of CYP1A1, CYP2E1, and GSTM1 and the risk of lung and urinary bladder cancers.
• To explore the combined effects of CYP1A1 and GSTM1 genotypes on lung cancer risk.
• To examine the role of gene-environment interactions, specifically cigarette exposure levels, in cancer susceptibility.

Main Methods:

• Genotyping analysis to identify high-risk alleles for CYP1A1, CYP2E1, and GSTM1.
• Case-control study design comparing cancer patients with control individuals.
• Statistical analysis to assess the risk associated with specific genotypes and their interactions with environmental factors like smoking.

Main Results:

• Increased risk of lung and urinary bladder cancers was observed in individuals with high-risk genotypes of CYP1A1, CYP2E1, or GSTM1.
• A significantly enhanced risk for lung cancer was found in individuals with the combined CYP1A1 and GSTM1 high-risk genotypes.
• Gene-environment interactions were more pronounced at lower levels of cigarette exposure, increasing lung cancer susceptibility in individuals with mutated alleles.

Conclusions:

• Specific genetic profiles (CYP1A1, CYP2E1, GSTM1) are associated with an increased risk of lung and urinary bladder cancers.
• Combined genetic effects and gene-environment interactions, especially with smoking, significantly modify cancer risk.
• Early identification of genetic predisposition could facilitate timely screening and diagnosis for cancer prevention and improved outcomes.